Phase I study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1, in solid tumors, as monotherapy or in combination with pembrolizumab

被引：0

作者：

Kyi, Chrisann

Van Dongen, Marloes

Rottey, Sylvie

Bermejo, Ignacio Melero

Mittag, Diana

Gouveia, Dane

Bol, Kees

Yan, Chris

Joe, Andrew K.

Laus, Gianluca

Moreno, Victor

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY USA

[2] Netherlands Canc Inst, Antoni Van Leeuwenhoek, Amsterdam, Netherlands

[3] Ghent Univ Hosp, Ghent, Belgium

[4] Univ Navarra Clin, Pamplona, Spain

[5] Merus NV, Utrecht, Netherlands

[6] Univ Hosp Fdn Jimenez Diaz, START Madrid FJD, Madrid, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2520

引用

页数：1